Related stories
Pfizer raises 2026 outlook on strong Eliquis demand
Pfizer raised its annual profit and revenue outlook, citing strong demand for its anticoagulant Eliquis.
M impact | EARNINGS | Nov 03, 2026, 02:22 PM UTC
화이자, 엘리퀴스 수요에 힘입어 2026년 실적 전망 상향
M impact | EARNINGS | Nov 03, 2026, 02:19 PM UTC
Wipro Consumer H1 Organic Revenue Rises 17% to Rs.6,094 Crore
Wipro Consumer Care and Lighting reported six-month organic revenue of Rs.6,094 crore through September 2026, citing resilient rural demand, premiumisation in small towns and growt
M impact | EARNINGS | Nov 03, 2026, 02:18 PM UTC
HS Optimus Holdings Expects Lower Revenue for Half-Year
M impact | EARNINGS | Nov 03, 2026, 02:12 PM UTC
Clariant Q3 EBITDA Falls as Sales Rise
Clariant reported a third-quarter fiscal 2026 EBITDA decline while sales increased. Care Chemicals and Adsorbents boosted sales, the headline says.
M impact | EARNINGS | Nov 03, 2026, 02:11 PM UTC
IndiQube Spaces September-quarter revenue from operations was 4.72 billion rupees
M impact | EARNINGS | Nov 03, 2026, 02:10 PM UTC